---
schema_version: "secwatch.filing_event.v1"
accession: "0000819050-23-000057"
form_type: "8-K"
ticker: null
cik: "0000819050"
company_name: "Fresh Tracks Therapeutics, Inc."
filed_at: "2023-07-25T23:59:59+00:00"
generated_at: "2026-06-13T03:42:21.594592+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director Robert Brown resigns from Fresh Tracks board; board reduced to 3 members; Nasdaq compliance regained

## Summary
- Robert B. Brown resigned from the Board effective July 24, 2023; no disagreement with operations or policies.
- Board reduced minimum number of directors from 4 to 3 via amended bylaws, and reduced board size to 3.
- Company regained Nasdaq compliance for independent director and audit committee requirements under Rule 5605.

## SEC filing metadata
- accession: 0000819050-23-000057
- form_type: 8-K
- cik: 0000819050
- company_name: Fresh Tracks Therapeutics, Inc.
- filed_at: 2023-07-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/819050/000081905023000057/0000819050-23-000057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/819050/000081905023000057/frtx-20230724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000819050-23-000057
- JSON: https://secwatch.observer/filing/0000819050-23-000057.json
- Plain text: https://secwatch.observer/filing/0000819050-23-000057.txt

## Key facts
- Executive change
  Robert B. Brown resigned as Director at Fresh Tracks Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 24, 2023, Robert B. Brown informed Fresh Tracks Therapeutics, Inc. (the “Company”) of his resignation from the Company’s Board of Directors (the “Board”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/819050/000081905023000057/0000819050-23-000057-index.htm
- Governance Changes
  Fresh Tracks Therapeutics, Inc.: Board adopted Amended and Restated Bylaws to reduce the minimum number of directors from four to three, and subsequently reduced the board size accordingly (effective 2023-07-24).
  - Change: bylaw amendment
  - Effective: 2023-07-24
  source text: On July 24, 2023, the Board adopted Amended and Restated Bylaws to decrease the minimum number of directors from four members to three members.
  evidence_url: https://www.sec.gov/Archives/edgar/data/819050/000081905023000057/0000819050-23-000057-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.